Kay Shigemori

3PUBLICATIONS
25CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 25, 2024
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.

Peter S Winter, Michelle L Ramseier, Andrew W Navia

|May 02, 2019
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.

Chen Lossos, Yunpeng Liu, Kellie E Kolb

|Dec 01, 2018
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.

Raphael Koch, Amanda L Christie, Jennifer L Crombie

Pageof 1